Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Go back to Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
(NASDAQ: PSTV) Delayed: 3.87 --0 (-0%)
Previous Close $3.87    52 Week High
Open $3.87    52 Week Low
Day High $3.87    P/E N/A 
Day Low $3.87    EPS
Volume 871